Melatonin vs Midazolam in Children Undergoing Tonsillectomy

Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age3-12
SponsorAin Shams University

About this trial

Used as a premedication to decrease anxiety (Caumo et al., 2007). Midazolam, though has several drawbacks (McCann and Kain, 2001). Hence, an alternative premedication to midazolam will definitely have a widespread appeal.

Melatonin is a hormone secreted by the pineal gland. Melatonin is different from benzodiazepines and their derivatives in that it exerts a promoting effect on sleep by amplifying day/night differences in alertness and sleep quality and displaying a modest sleep-inducing effect, quite mild as compared to that seen with benzodiazepines (Ahmad et al., 2007). Melatonin has also been reported to cause preoperative anxiolysis and an increase in levels of sedation without impairing orientation (Naguib and Samarkandi, 2000). Hence, the aim of this study is to compare the effect of oral melatonin and oral midazolam on preoperative anxiety.

Emergence delirium (ED) was first described in the literature in the early 1960s. Although often used interchangeably with emergence agitation, it is defined as a temporary dissociated state of consciousness after discontinuation of anesthesia. The characteristics that make up ED include irritability, inconsolable crying, distress and inability to cooperate (Reduque and Verghese, 2013).

Midazolam is the most prescribed oral premedication in the preoperative setting. Its benefits include preoperative anxiolysis, amnesia, relatively rapid onset and short duration of action. Although most children have anxiolysis with midazolam, up to 29% may display a paradoxical agitation response (Shin et al., 2013).

Oral melatonin doses up to 0.4 mg/kg (maximum 20 mg) are effective in reducing ED in children (age 3-7 years) (Kain et al., 2009).

AIM OF THE WORK The study aims to compare the effects of oral melatonin and oral midazolam on preoperative anxiety as a premedication in children undergoing tonsillectomy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

chest infection

Abnormal mental milestones.

Children with any organ dysfunction.

Allergies to any of the drugs used.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Melatonin group

    Drug

    All patients will be subjected to a thorough medical history, physical examination, and routine preoperative investigations will be done to all children, including laboratory investigations (complete blood picture, bleeding time, prothrombin time, and partial thromboplastin time). Age, weight, and sex will be recorded. One hour before sedation, children will be transported to an isolated recovery room near the operating room. Parental presence will be allowed throughout the sedation and post-sedation period. Patients will receive 0.3 mg per kg oral melatonin in 10 ml Dextrose 10% 45 min before surgery (Maximum dose 10mg). Assessment of sedation and anxiolysis 30 min after the drug administration using Ramsay sedation scale.

  • Midazolam group

    Drug

    All patients will be subjected to a thorough medical history, physical examination, and routine preoperative investigations will be done to all children, including laboratory investigations (complete blood picture, bleeding time, prothrombin time, and partial thromboplastin time). Age, weight, and sex will be recorded. One hour before sedation, children will be transported to an isolated recovery room near the operating room. Parental presence will be allowed throughout the sedation and post-sedation period. Patients will receive 0.3 mg per kg oral midazolam in 10 ml Dextrose 10% 45 min before surgery (Maximum dose 10mg). Assessment of sedation and anxiolysis 30 min after the drug administration using Ramsay sedation scale.

  • Control group

    Drug

    All patients will be subjected to a thorough medical history, physical examination, and routine preoperative investigations will be done to all children, including laboratory investigations (complete blood picture, bleeding time, prothrombin time, and partial thromboplastin time). Age, weight, and sex will be recorded. One hour before sedation, children will be transported to an isolated recovery room near the operating room. Parental presence will be allowed throughout the sedation and post-sedation period. Patients will receive 10 ml pure oral Dextrose 10% 45 min before surgery. Assessment of sedation and anxiolysis 30 min after the drug administration using Ramsay sedation scale.

Treatment groups

195 Participants
are divided into 3 treatment groups
Group A: Melatonin group (Group M)Active comparator 1 intervention
Group B: Midazolam group (Group D)Sham comparator 1 intervention
Group C: placebo group (Group C)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of preoperative anxiety with oral melatonin vs oral midazolam as a premedication in Children Undergoing Tonsillectomy.

Assessment of sedation 30 min after the drug administration using Ramsay sedation scale.

Time frame
30 minutes after giving the drug

Secondary outcomes

1

1. Effect of both drugs in reducing incidence of post operative emergence delerium

Pediatric Anesthesia Emergence Delirium (PAED) Scale Score. The PAED scale consists of 5 criteria that are scored using a 5-point scale. The scores of each criterion are added to make a total score. The maximum achievable score is 20. A score of ≥10 has 64% sensitivity and 86% specificity for the diagnosis of ED. A score of \>12 has 100% sensitivity and 94.5% specificity for the diagnosis of ED

Time frame
24 hours afer the procedure

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: